Maternal Serum CA125 Is Not a Second Trimester Marker for Down's Syndrome

Annals of Clinical Biochemistry - United Kingdom
doi 10.1177/000456329102800318
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Early Second Trimester hCG of Maternal Serum as Predictor Marker for Pregnancy Induced Hypertension

Medicine & Health
2018English

Feature Article: Identification of Differential Proteins in Maternal Serum With Down's Syndrome

Experimental Biology and Medicine
MedicineBiochemistryGeneticsMolecular Biology
2012English

Serum Gonadotrophins in Down's Syndrome

Journal of Medical Genetics
Genetics
1982English

First Trimester Maternal Serum Screening for Down's Syndrome: An Evaluation of the DPC Immulite 2000 Free Β-hCG and Pregnancy-Associated Plasma Protein-A Assays

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2005English

EP18.16: Second Trimester Sludge as a Marker for Preterm Birth

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Interference in the autoDELFIA(R) hAFP Immunoassay and Effect on Second-Trimester Down's Syndrome Screening

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2011English

Early Second-Trimester Maternal Serum Markers in Prediction of Gestational Diabetes Mellitus

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Is Down's Syndrome a Progressive Condition?

Journal of the Royal Society of Medicine
Medicine
1985English

First Trimester Screening for Trisomy 21 in Gestational Week 8-10 by ADAM12-S as a Maternal Serum Marker

Reproductive Biology and Endocrinology
GynecologyEndocrinologyReproductive MedicineDevelopmental BiologyObstetrics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy